Brief: Glycomimetics Reports Highlights And Financial Results For Third Quarter 2022
09/11/2022 12:19
Nov 9 (Reuters) - GlycoMimetics Inc GLYC.O :
* GLYCOMIMETICS REPORTS HIGHLIGHTS AND FINANCIAL RESULTS FOR
THIRD
QUARTER 2022
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.16
* CASH RUNWAY EXTENDED TO END OF 2023
Source text for Eikon: ID:nBw9qSQVZa
Further company coverage: GLYC.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Crescent Biopharma
See all newsBrief: Crescent Biopharma - Potential To Initiate First CR-001 Phase 3 Study In Early 2028
Brief: Crescent Biopharma Announces FDA Clearance Of Ind Application For CR-002, A Pd-L1-Targeted Topoisomerase Inhibitor Adc, For The Treatment Of Solid Tumors
Crescent Biopharma posts smaller-than-expected Q2 net loss
U.S. STOCKS ON THE MOVE-Cintas, Veradermics
Crescent Biopharma slips on $125 mln share offering